Victoria Forster

Once solely engaged as participants in academic studies and research, patients are increasingly becoming more involved at several stages of the research process. From helping large organisations assess grants and prioritise funding calls to participating actively in teams running research…

An older woman receiving treatment for breast cancer sits at home wondering whether to call her physician and go into the hospital. She’s on a new dose of a drug which she hasn’t had before and is struggling with nausea.…

A new survey of 1,871 people living with cancer in the UK and US has revealed significant differences in the terms that they would like to be used to describe themselves. Descriptive terms such as “victim,” “sufferer” and “cancer stricken”…

Childhood cancer is considered a success story of modern medicine, with more than 90% of children now surviving long-term in high-income countries, up from just 10% 65 years ago. Yet many children who survive their cancer go on to experience…

Chimeric antigen receptor (CAR) T cells, genetically engineered immune cells targeted to attack cancers, are one of the most exciting breakthrough cancer treatments in oncology today. After decades of incremental development, its clinical efficacy was shown in 2010, with the…

A new organisation set up to amplify Black voices and contributions to oncology is making its mark, two years since its foundation. An inaugural London conference in October, supported by Cancer Research UK, included presentations by Black researchers, career talks…

When diagnosed with cancer, few things are more important than having confidence that the treatment you are prescribed is the best possible option for you. For many cancers, particularly the more common ones, the evidence for choosing one option over…